login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ADMA BIOLOGICS INC (ADMA) Stock News
NASDAQ:ADMA -
US0008991046
-
Common Stock
17.2
USD
-0.06 (-0.35%)
Last: 9/2/2025, 8:00:00 PM
16.8
USD
-0.4 (-2.33%)
After Hours:
9/2/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ADMA Latest News, Press Relases and Analysis
All
Press Releases
6 days ago - By: Yahoo Finance
- Mentions:
VZ
ADMA Biologics, Inc. (ADMA): A Bull Case Theory
a month ago - By: Zacks Investment Research
- Mentions:
CRMD
IMCR
ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum
a month ago - By: Benzinga
- Mentions:
LNW
ATRO
EXAS
TNDM
...
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
a month ago - By: Benzinga
- Mentions:
EXAS
TNDM
IRWD
OM
...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
a month ago - By: The Motley Fool
Adma Biologics (ADMA) Q2 Revenue Up 14%
a month ago - By: Zacks Investment Research
- Mentions:
PBYI
Adma Biologics (ADMA) Q2 Earnings and Revenues Beat Estimates
a month ago - By: ADMA Biologics, Inc.
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
a month ago - By: ADMA Biologics, Inc.
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
2 months ago - By: Zacks Investment Research
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market
3 months ago - By: Zacks Investment Research
- Mentions:
GRFS
TAK
ADMA Stock Gains 17% in Three Months: Buy, Sell or Hold?
a month ago - By: ADMA Biologics, Inc.
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
a month ago - By: ADMA Biologics, Inc.
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
a month ago - By: Yahoo Finance
Heavy Insider Selling at ADMA Biologics Despite Earnings Strength
2 months ago - By: Yahoo Finance
- Mentions:
FIS
ADMA Biologics (ADMA) Drops 14.7% W/W as 3 Execs Unload Portfolios
3 months ago - By: Zacks Investment Research
Are Options Traders Betting on a Big Move in ADMA Biologics Stock?
3 months ago - By: Yahoo Finance
- Mentions:
FIS
ADMA Biologics (ADMA) Drops for 5th Consecutive Day – Here’s Why
3 months ago - By: Yahoo Finance
- Mentions:
NVDA
CRWV
MSFT
SPOT
...
Is CoreWeave a Buy?
3 months ago - By: Yahoo Finance
- Mentions:
PLTR
AVGO
NVDA
CRWD
...
Palantir (PLTR) Price Target Raised to $116 Despite ‘Underperform’ Rating
3 months ago - By: Yahoo Finance
- Mentions:
OKLO
NVDA
CRWV
QUBT
...
Oklo Inc (OKLO) – Jumps 30% After New Government Deal
3 months ago - By: Zacks Investment Research
- Mentions:
IVZ
AWI
CORT
Should Invesco S&P SmallCap Quality ETF (XSHQ) Be on Your Investing Radar?
3 months ago - By: Zacks Investment Research
- Mentions:
GRFS
ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy?
4 months ago - By: Zacks Investment Research
- Mentions:
SNY
BEAM
KYMR
Kymera' s Q1 Loss Narrower Than Expected, Pipeline Progress Encouraging
4 months ago - By: Zacks Investment Research
- Mentions:
BEAM
PCRX
Pacira BioSciences Q1 Earnings Beat, Revenues Miss Estimates
4 months ago - By: Zacks Investment Research
- Mentions:
BEAM
RCKT
RCKT's Q1 Loss Narrower Than Expected, Pipeline in Focus
4 months ago - By: Zacks Investment Research
- Mentions:
PBYI
ANIP
IMCR
PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates
4 months ago - By: Zacks Investment Research
- Mentions:
GRFS
TAK
ADMA's Q1 Earnings and Revenues Miss: Buy, Sell or Hold the Stock?
Please enable JavaScript to continue using this application.